79 related articles for article (PubMed ID: 22750740)
1. Intra-articular controlled release of anti-inflammatory siRNA with biodegradable polymer microparticles ameliorates temporomandibular joint inflammation.
Mountziaris PM; Tzouanas SN; Sing DC; Kramer PR; Kasper FK; Mikos AG
Acta Biomater; 2012 Oct; 8(10):3552-60. PubMed ID: 22750740
[TBL] [Abstract][Full Text] [Related]
2. Red blood cell membrane-camouflaged poly(lactic-co-glycolic acid) microparticles as a potential controlled release drug delivery system for local stellate ganglion microinjection.
Liu B; Zhang D; Tu H; Alimi OA; Kong Y; Satyanarayana R; Kuss M; Li Y; Duan B
Acta Biomater; 2023 Apr; 161():201-212. PubMed ID: 36858164
[TBL] [Abstract][Full Text] [Related]
3. Sustained low-dose dexamethasone delivery via a PLGA microsphere-embedded agarose implant for enhanced osteochondral repair.
Stefani RM; Lee AJ; Tan AR; Halder SS; Hu Y; Guo XE; Stoker AM; Ateshian GA; Marra KG; Cook JL; Hung CT
Acta Biomater; 2020 Jan; 102():326-340. PubMed ID: 31805408
[TBL] [Abstract][Full Text] [Related]
4. Polyvinylamine and Its Derivative as Effective Carrier for Targeted Delivery of Small RNAs.
Tian Y; Patil S; Deng X; Zhao Y; Sang B; Qian A
Methods Mol Biol; 2024; 2822():353-365. PubMed ID: 38907928
[TBL] [Abstract][Full Text] [Related]
5. EGFP-EGF1-conjugated PLGA nanoparticles for targeted delivery of siRNA into injured brain microvascular endothelial cells for efficient RNA interference.
Chen C; Mei H; Shi W; Deng J; Zhang B; Guo T; Wang H; Hu Y
PLoS One; 2013; 8(4):e60860. PubMed ID: 23593330
[TBL] [Abstract][Full Text] [Related]
6. Local delivery of RhoA siRNA by PgP nanocarrier reduces inflammatory response and improves neuronal cell survival in a rat TBI model.
Macks C; Jeong D; Lee JS
Nanomedicine; 2021 Feb; 32():102343. PubMed ID: 33259960
[TBL] [Abstract][Full Text] [Related]
7. Intranasal brain delivery of cationic nanoemulsion-encapsulated TNFα siRNA in prevention of experimental neuroinflammation.
Yadav S; Gandham SK; Panicucci R; Amiji MM
Nanomedicine; 2016 May; 12(4):987-1002. PubMed ID: 26767514
[TBL] [Abstract][Full Text] [Related]
8. Biomaterial-mediated intracellular control of macrophages for cell therapy in pro-inflammatory and pro-fibrotic conditions.
Tylek T; Wong J; Vaughan AE; Spiller KL
Biomaterials; 2024 Jul; 308():122545. PubMed ID: 38547831
[TBL] [Abstract][Full Text] [Related]
9. Peptide- and Amine-Modified Glucan Particles for the Delivery of Therapeutic siRNA.
Cohen JL; Shen Y; Aouadi M; Vangala P; Tencerova M; Amano SU; Nicoloro SM; Yawe JC; Czech MP
Mol Pharm; 2016 Mar; 13(3):964-978. PubMed ID: 26815386
[TBL] [Abstract][Full Text] [Related]
10. Pulmonary Delivery of siRNA via Polymeric Vectors as Therapies of Asthma.
Xie Y; Merkel OM
Arch Pharm (Weinheim); 2015 Oct; 348(10):681-8. PubMed ID: 26148454
[TBL] [Abstract][Full Text] [Related]
11. Drug delivery systems for treatment of temporomandibular joint osteoarthritis.
Huang X; Pan X; Xiong X; Zhao Z; Cen X
Front Pharmacol; 2022; 13():1054703. PubMed ID: 36419625
[TBL] [Abstract][Full Text] [Related]
12. Top-Down Fabricated microPlates for Prolonged, Intra-articular Matrix Metalloproteinase 13 siRNA Nanocarrier Delivery to Reduce Post-traumatic Osteoarthritis.
Bedingfield SK; Colazo JM; Di Francesco M; Yu F; Liu DD; Di Francesco V; Himmel LE; Gupta MK; Cho H; Hasty KA; Decuzzi P; Duvall CL
ACS Nano; 2021 Sep; 15(9):14475-14491. PubMed ID: 34409835
[TBL] [Abstract][Full Text] [Related]
13. Toward a Better Regeneration through Implant-Mediated Immunomodulation: Harnessing the Immune Responses.
Zhang B; Su Y; Zhou J; Zheng Y; Zhu D
Adv Sci (Weinh); 2021 Aug; 8(16):e2100446. PubMed ID: 34117732
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic Agents for the Treatment of Temporomandibular Joint Disorders: Progress and Perspective.
Wu M; Cai J; Yu Y; Hu S; Wang Y; Wu M
Front Pharmacol; 2020; 11():596099. PubMed ID: 33584275
[TBL] [Abstract][Full Text] [Related]
15. Macrophages Are Key Regulators of Stem Cells during Skeletal Muscle Regeneration and Diseases.
Dort J; Fabre P; Molina T; Dumont NA
Stem Cells Int; 2019; 2019():4761427. PubMed ID: 31396285
[TBL] [Abstract][Full Text] [Related]
16. Biomaterials: Foreign Bodies or Tuners for the Immune Response?
Mariani E; Lisignoli G; Borzì RM; Pulsatelli L
Int J Mol Sci; 2019 Feb; 20(3):. PubMed ID: 30717232
[TBL] [Abstract][Full Text] [Related]
17. Intra-articular biomaterials-assisted delivery to treat temporomandibular joint disorders.
Dashnyam K; Lee JH; Mandakhbayar N; Jin GZ; Lee HH; Kim HW
J Tissue Eng; 2018; 9():2041731418776514. PubMed ID: 29785258
[TBL] [Abstract][Full Text] [Related]
18. Engineered Hydrogels for Local and Sustained Delivery of RNA-Interference Therapies.
Wang LL; Burdick JA
Adv Healthc Mater; 2017 Jan; 6(1):. PubMed ID: 27976524
[TBL] [Abstract][Full Text] [Related]
19. Photocleavable Hydrogels for Light-Triggered siRNA Release.
Huynh CT; Nguyen MK; Tonga GY; Longé L; Rotello VM; Alsberg E
Adv Healthc Mater; 2016 Feb; 5(3):305-310. PubMed ID: 26639103
[TBL] [Abstract][Full Text] [Related]
20. Technologies for controlled, local delivery of siRNA.
Sarett SM; Nelson CE; Duvall CL
J Control Release; 2015 Nov; 218():94-113. PubMed ID: 26476177
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
